share_log

Cytosorbents | 8-K: CytoSorbents Reports Third Quarter 2022 Financial and Operational Results CytoSorbents expects to achieve first milestone of the U.S. pivotal STAR-T Trial this month

SEC ·  Nov 4, 2022 05:23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more